Prostate cancer radiation after surgery: standard vs personalized dose
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two types of radiation for men who have had their prostate removed, to see if a dose tailored to their risk is just as good or better. It aims to reduce side effects while keeping the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had surgery to remove your prostate at least 6 months ago.
- Your doctor has recommended radiation because of signs like a rising PSA or remaining cancer cells.
- You are generally able to take care of yourself (WHO performance 0-1).
- You are 18 or older.
- You have not had radiation to this area before.
- You do not have cancer that has spread to distant organs (but small lymph node spread is okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a tailored (personalized) radiation plan for men whose PSA (“prostate blood test”) rises after prostate surgery but who have no detectable spread on scans. It may help control cancer growth by targeting the right area based on your situation.
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
This trial tests a precise type of radiation (called SBRT) to the prostate bed for men whose PSA starts rising after prostate removal surgery. It aims to see if this targeted approach can effectively treat the recurrence without needing long-term hormone therapy.
This trial studies a “daily adaptive” way of planning and delivering radiation after prostate surgery to treat prostate cancer that is coming back locally. It may help target the tumor more precisely while limiting radiation to healthy tissue.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This trial looks at radiation therapy given after prostate surgery (or if needed later) for prostate cancer where lymph nodes were not involved. It may help patients whose PSA rises or who need additional treatment to reduce the chance the cancer comes back.
Hear when a new Prostate Cancer (Post Prostatectomy) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.